newsfilter
← Latest News
GlobeNewswire·

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates